TCW Group’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.92M Sell
41,050
-619,474
-94% -$48.8M 0.02% 239
2025
Q4
$54.2M Sell
660,524
-4,691
-0.7% -$366K 0.39% 70
2025
Q3
$50M Sell
665,215
-77,412
-10% -$5.77M 0.42% 64
2025
Q2
$55M Buy
742,627
+68,260
+10% +$4.75M 0.43% 61
2025
Q1
$54.4M Buy
674,367
+85,247
+14% +$7.33M 0.49% 58
2024
Q4
$46.1M Buy
589,120
+55,768
+10% +$4.74M 0.39% 68
2024
Q3
$50.1M Buy
533,352
+33,937
+7% +$2.85M 0.44% 68
2024
Q2
$38.9M Buy
499,415
+125,612
+34% +$10.2M 0.35% 74
2024
Q1
$34M Buy
373,803
+16,765
+5% +$1.39M 0.34% 70
2023
Q4
$27.6M Sell
357,038
-71,643
-17% -$5.02M 0.31% 73
2023
Q3
$29.2M Sell
428,681
-48,201
-10% -$3.51M 0.37% 70
2023
Q2
$38.7M Buy
476,882
+129,776
+37% +$10.4M 0.43% 66
2023
Q1
$28.5M Buy
+347,106
New +$24.8M 0.36% 73

Other funds holding GEHC

TCW Group's GEHC Position: Q1 2026 in Review

TCW Group reduced its GE HealthCare (GEHC) stake by 94% in Q1 2026, selling an estimated $48.8M and leaving 41,050 shares worth $2.92M. The position accounts for 0.02% of the portfolio, ranked #239.

TCW Group first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $55M in Q2 2025. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • TCW Group held 41,050 shares of GE HealthCare worth $2.92M as of Q1 2026.
  • TCW Group sold 619,474 GE HealthCare shares in Q1 2026, an estimated $48.8M.
  • GE HealthCare made up 0.02% of TCW Group's portfolio in Q1 2026, its #239 holding.
  • TCW Group first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • TCW Group's GE HealthCare position peaked at $55M in Q2 2025.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on TCW Group's 13F filing for Q1 2026, filed 14 May 2026.